BIIB
Biogen Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #59
- Final score
- 68.00
- Years on list
- 6
↗ Climbed 3 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- BIIB· Biogen Inc.
- GILD· Gilead Sciences, Inc.
- ABBV· AbbVie Inc.
Figure 01 · Side-by-side summary
The headline numbers
GILD
Gilead Sciences, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #43
- Final score
- 69.57
- Years on list
- 6
↗ Climbed 139 since 2020
ABBV
AbbVie Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #79
- Final score
- 67.00
- Years on list
- 6
↘ Down 52 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | BIIB | GILD | ABBV |
|---|---|---|---|
| Climate Change | 92.1 | 82.3 | 74.0 |
| Employee Relations | 67.8 | 77.8 | 56.1 |
| Environment | 59.2 | 67.9 | 71.1 |
| Stakeholders & Society | 69.9 | 74.4 | 77.8 |
| Human Rights | 52.9 | 41.7 | 60.2 |
| Governance | 47.7 | 54.7 | 59.5 |
| Performance Rating | 59.9 | 59.3 | 63.6 |